Company Directory > CRO > Lexbridge Co., Ltd.
Lexbridge Co., Ltd. is a specialized pharmaceutical and biotechnology consulting firm based in Osaka, Japan. Founded in 2025, the company provides comprehensive support for international life sciences companies entering the Japanese market. Their services focus on regulatory affairs (RA), quality assurance (QA), and strategic market access, helping clients navigate the requirements of the Pharmaceuticals and Medical Devices Agency (PMDA) and the Ministry of Health, Labour and Welfare (MHLW). The firm is particularly distinguished by its deep scientific foundation, led by experts in virology and molecular biology. Lexbridge acts as a 'bridge' for global innovation, offering specialized consulting in infectious diseases, vaccines, and advanced therapeutic modalities. They often serve as a strategic partner for small-to-mid-sized biotechs that lack a physical presence in Japan, providing the necessary local expertise to manage clinical development and regulatory submissions.
CLASSIFICATION
Company Type:CRO
Industry:Pharmaceuticals
Sub-Industry:Regulatory Consulting & Market Access
SIZE & FINANCIALS
Employees:1-50
Founded:2025
Ownership:private
Status:operating
PIPELINE
Stage:Commercial
Lead Drug Stage:N/A (Service Provider)
Modalities:Vaccines, Small molecule, Gene therapy, RNA therapeutics
Active Trials:0
Trial Phases:-
FDA Approvals:0
EMA Approvals:0
CORPORATE STRUCTURE
Key Partnerships:Tokyo Metropolitan Institute of Medical Science (Academic connection), University of Leeds (Academic connection)
COMPETITION
Position:Niche Player
Competitors:EPS Corporation, CMIC Group, Intage Healthcare, A2 Healthcare
LEADERSHIP
Key Executives:
Yutaka Amako - CEO & Representative Director
Scientific Founders:Yutaka Amako
LINKS
Disclaimer: IntuitionLabs.ai is not affiliated with, endorsed by, or associated with Lexbridge Co., Ltd.. The information on this page was collected and compiled using AI agents from publicly available sources. While we strive for accuracy, this data may be incomplete, outdated, or contain errors. For official information, please visit the company's website directly. If you notice any inaccurate information, please contact us.